Literature DB >> 12785698

Altered in vitro immune responses in green turtles (Chelonia mydas) with fibropapillomatosis.

C Cray1, R Varella, G D Bossart, P Lutz.   

Abstract

The immune competence of green sea turtles (Chelonia mydas) with fibropapillomatosis was assessed using in vitro techniques to measure lymphocyte proliferation in response to mitogens. In comparison with captive, healthy green sea turtles, those afflicted with fibropapillomas demonstrated diminished proliferation with Concanavalin A, phytohemagglutinin (T-cell mitogens), and lipopolysaccharide (B-cell mitogen). Also, markedly decreased proliferative responses to the lymphocyte polyclonal stimulator combination of ionomycin and phorbol myristate acetate were observed. Total circulating white blood cell counts were not statistically different between the two groups, although an overall decrease in lymphocyte number was observed in the papilloma group. The albumin/globulin ratio was decreased in the papilloma group because of decreased albumin and increased gamma globulins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12785698     DOI: 10.1638/1042-7260(2001)032[0436:AIVIRI]2.0.CO;2

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  9 in total

1.  Differences in Antibody Responses against Chelonid Alphaherpesvirus 5 (ChHV5) Suggest Differences in Virus Biology in ChHV5-Seropositive Green Turtles from Hawaii and ChHV5-Seropositive Green Turtles from Florida.

Authors:  Thierry M Work; Julie Dagenais; Anna Willimann; George Balazs; Kate Mansfield; Mathias Ackermann
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

2.  Influence of Sunlight on Vitamin D and Health Status in Green (Chelonia mydas) Sea Turtles with Fibropapillomatosis.

Authors:  Victoria E Garefino; Sarah L Milton
Journal:  Animals (Basel)       Date:  2022-02-16       Impact factor: 2.752

3.  Associations between organochlorine contaminant concentrations and clinical health parameters in loggerhead sea turtles from North Carolina, USA.

Authors:  Jennifer M Keller; John R Kucklick; M Andrew Stamper; Craig A Harms; Patricia D McClellan-Green
Journal:  Environ Health Perspect       Date:  2004-07       Impact factor: 9.031

4.  A double antibody sandwich enzyme-linked immunosorbent assay for detection of soft-shelled turtle iridovirus antigens.

Authors:  M Zhang; J X Yang; X M Lin; C H Zhu; J Q He; H Liu; T L Lin
Journal:  J Virol Methods       Date:  2010-04-23       Impact factor: 2.014

5.  Adaptive evolution of major histocompatibility complex class I immune genes and disease associations in coastal juvenile sea turtles.

Authors:  Katherine R Martin; Katherine L Mansfield; Anna E Savage
Journal:  R Soc Open Sci       Date:  2022-02-09       Impact factor: 2.963

6.  Haematological and immunological characteristics of eastern hellbenders (Cryptobranchus alleganiensis alleganiensis) infected and co-infected with endo- and ectoparasites.

Authors:  William A Hopkins; Jesse A Fallon; Michelle L Beck; Brittney H Coe; Catherine M B Jachowski
Journal:  Conserv Physiol       Date:  2016-03-21       Impact factor: 3.079

7.  Establishment of reference intervals for plasma protein electrophoresis in Indo-Pacific green sea turtles, Chelonia mydas.

Authors:  Mark Flint; Beren J Matthews; Colin J Limpus; Paul C Mills
Journal:  Conserv Physiol       Date:  2015-09-02       Impact factor: 3.079

Review 8.  Sea turtles: old viruses and new tricks.

Authors:  Adam G Jones
Journal:  Curr Biol       Date:  2004-10-05       Impact factor: 10.834

9.  Insights on Immune Function in Free-Ranging Green Sea Turtles (Chelonia mydas) with and without Fibropapillomatosis.

Authors:  Justin R Perrault; Milton Levin; Cody R Mott; Caitlin M Bovery; Michael J Bresette; Ryan M Chabot; Christopher R Gregory; Jeffrey R Guertin; Sarah E Hirsch; Branson W Ritchie; Steven T Weege; Ryan C Welsh; Blair E Witherington; Annie Page-Karjian
Journal:  Animals (Basel)       Date:  2021-03-18       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.